Mario Eduardo GUIDO

Dr. Mario Eduardo GUIDO


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2020 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MGMario Eduardo GUIDO
Mario Eduardo GUIDO
NMNatalia A. Marchese
Natalia A. Marchese
MRMaximiliano N. Rios
Maximiliano N. Rios
LMLuis P. Morera
Luis P. Morera
NDNicolás M. Diaz
Nicolás M. Diaz
María Ana ContinMaría Ana Contin
María Ana Contin

1 January 2019 in ASN Neuro
Verified
Journal Article
Open access
PDF file
PWPaula M. Wagner
Paula M. Wagner
NMNatalia M. Monjes
Natalia M. Monjes
MGMario Eduardo GUIDO
Mario Eduardo GUIDO
Glioblastoma multiforme is the most aggressive brain tumor, and human T98G cells constitute a useful glioblastoma multiforme model to evaluate the chemotherapeutic agents. Modern life (shiftwork, jetlag, etc.) may cause circadian disorganization promoting higher cancer risk and metabolic disorders. Although little is known about the tumor-intrinsic circadian clock function, pharmacological modulation of circadian components may offer selective anticancer strategies. REV-ERBs are heme-binding circadian clock components acting as repressors of processes involved in tumorigenesis such as metabolism, proliferation, and inflammation. A synthetic pyrrole derivative (SR9009) that acts as REV-ERBs-specific agonists exhibits potent in vivo activity on metabolism and tumor cell viability. Here, we investigated SR9009 effects on T98G cell viability, differential chemotherapy time responses, and underlying metabolic processes (reactive oxygen species [ROS] and lipid droplets [LDs]) and compared it with the proteasome inhibitor Bortezomib treatment. SR9009-treated cells exhibited significant reduction in cell viability with consequences on cell cycle progression. Dexamethasone synchronized cells displayed differential time responses to SR9009 treatment with highest responses 18 to 30 h after synchronization. SR9009 treatment decreased ROS levels while Bortezomib increased them. However, both treatments significantly increased LD levels, whereas the combined treatment showed additive or synergistic effects between both drugs. In addition, we extended these studies to HepG2 cells which also showed a significant decrease in cell viability and ROS levels and the increase in LD levels after SR9009 treatment. Our results suggest that the pharmacological modulation of the tumor-intrinsic clock by REV-ERB agonists severely affects cell metabolism and promotes cytotoxic effects on cancer cells.

1 July 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
DVDaniela M. Verra
Daniela M. Verra
María Ana ContinMaría Ana Contin
María Ana Contin
DHDavid Hicks
David Hicks
MGMario Eduardo GUIDO
Mario Eduardo GUIDO
Purpose.: Retinal ganglion cells (RGCs) expressing the photopigment melanopsin (Opn4) display intrinsic photosensitivity. In this study, the presence of nonvisual phototransduction cascade components in the developing chicken retina and primary RGCs cultures was investigated, focusing on the two Opn4 genes: the Xenopus (Opn4x) and the mammalian (Opn4m) orthologs. Methods.: Retinas were dissected at different embryonic (E) and postnatal (P) days, and primary RGC cultures were obtained at E8 and kept for 1 hour to 5 days. Samples were processed for RT-PCR and immunochemistry. Results.: Embryonic retinas expressed the master eye gene Pax6, the prospective RGC specification gene Brn3, and components of the nonvisual phototransduction cascade, such as Opn4m and the G protein q (Gq) mRNAs at very early stages (E4–E5). By contrast, expression of photoreceptor cell markers (CRX, red-opsin, rhodopsin, and α-transducin) was observed from E7 to E12. Opn4m protein was visualized in the whole retina as early as E4 and remained elevated from E6 to the postnatal days, whereas Opn4x was weakly detected at E8 and highly expressed after E11. RGC cultures expressed Gq mRNA, as well as both Opn4 mRNAs and proteins. Opn4m was restricted exclusively to the GC layer at all ages, whereas Opn4x was limited to the forming GC layer and optic nerve at E8, but by E15, its expression was mostly in Prox1(+) horizontal cells. Conclusions.: The early expression onset of nonvisual phototransduction molecules could confer premature photosensitivity to RGCs, while the appearance of Opn4x expression in horizontal cells suggests the identification of a novel type of photosensitive cell in birds.

26 October 2021 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MGMario Eduardo GUIDO
Mario Eduardo GUIDO
NMNatalia M. Monjes
Natalia M. Monjes
PWPaula M. Wagner
Paula M. Wagner
GSGabriela A. Salvador
Gabriela A. Salvador

11 January 2021 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
PWPaula M. Wagner
Paula M. Wagner
CPCésar G. Prucca
César G. Prucca
FVFabiola N. Velazquez
Fabiola N. Velazquez
LALucas G. Sosa Alderete
Lucas G. Sosa Alderete
BCBeatriz L. Caputto
Beatriz L. Caputto
MGMario Eduardo GUIDO
Mario Eduardo GUIDO
Tumors of the nervous system including glioblastoma multiforme (GBM) are the most frequent and aggressive form of brain tumors; however, little is known about the impact of the circadian timing system on the formation, growth, and treatment of these tumors. We investigated day/night differences in tumor growth after injection of A530 glioma cells isolated from malignant peripheral nerve sheath tumor (MPNSTs) of NPcis ( Trp53 +/− ; Nf1 +/− ) mice. Synchronized A530 cell cultures expressing typical glial markers were injected at the beginning of the day or night into the sciatic nerve zone of C57BL/6 mice subject to a 12:12 hours light/dark (LD) cycle or after being released to constant darkness (DD). Tumors generated in animals injected early at night in the LD cycle or in DD showed higher growth rates than in animals injected diurnally. No differences were found when animals were injected at the same time with cultures synchronized 12 hours apart. Similar experiments performed with B16 melanoma cells showed higher tumor growth rates in animals injected at the beginning of the night compared to those injected in the daytime. A higher tumor growth rate than that in controls was observed when mice were injected with knocked‐down clock gene Bmal 1 cells. Finally, when we compared day/night administration of different doses of the proteasome inhibitor Bortezomib (0.5‐1.5 mg/kg) in tumor‐bearing animals, we found that low‐dose chemotherapy displayed higher efficacy when administered at night. Results suggest the existence of a precise temporal control of tumor growth and of drug efficacy in which the host state and susceptibility are critical.

17 October 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PNPaula S. Nieto
Paula S. Nieto
DVDiego J. Valdez
Diego J. Valdez
VAVictoria A. Acosta-Rodríguez
Victoria A. Acosta-Rodríguez
MGMario Eduardo GUIDO
Mario Eduardo GUIDO
The vertebrate retina is known to contain three classes of photoreceptor cells: cones and rods responsible for vision, and intrinsically photoresponsive retinal ganglion cells (RGCs) involved in diverse non-visual functions such as photic entrainment of daily rhythms and pupillary light responses. In this paper we investigated the potential intrinsic photoresponsiveness of the rat RGC line, RGC-5, by testing for the presence of visual and non-visual opsins and assessing expression of the immediate-early gene protein c-Fos and changes in intracellular Ca2+mobilization in response to brief light pulses. Cultured RGC-5 cells express a number of photopigment mRNAs such as retinal G protein coupled receptor (RGR), encephalopsin/panopsin (Opn3), neuropsin (Opn5) and cone opsin (Opn1mw) but not melanopsin (Opn4) or rhodopsin. Opn5 immunoreactivity was observed in RGC-5 cells and in the inner retina of rat, mainly localized in the ganglion cell layer (GCL). Furthermore, white light pulses of different intensities and durations elicited changes both in intracellular Ca2+ levels and in the induction of c-Fos protein in RGC-5 cell cultures. The results demonstrate that RGC-5 cells expressing diverse putative functional photopigments display intrinsic photosensitivity which accounts for the photic induction of c-Fos protein and changes in intracellular Ca2+ mobilization. The presence of Opn5 in the GCL of the rat retina suggests the existence of a novel type of photoreceptor cell.